NtPills Pharmacy Information Prescription medications. Information, Side Effects, Interactions.

online pharmacy:	minimal price:	best buy:	shipping:	payment method:	delivery to:
Qblh	- - -	- - -	14/free		most countries
Tl-Pharmacy	- - -	- - -	10-21 days/free		every country
MedRx-One	- - -	- - -	10 days/free		most countries
LeadMedic	- - -	- - -	14-21days/$10 5-7 days/$25		every country
Pharma-Doc	- - -	- - -	FedEx next day/$24		USA only
Med-Pen	- - -	- - -	14-20 days/$10 7-14 days/$20		most countries
OurPharmacyRx	- - -	- - -	14-21 days/$15 5-12 days/$30		most countries
RxPharms	- - -	- - -	14-24 days/free		worldwide
Mx-Pharma	- - -	- - -	8-16 days/$20 5-9 days/$30 3-6 days/$40		most countries

Indications for Use.

Depressive states (acute phase and supporting therapy).

Action

Antidepressive performance is developing during 2 weeks after the beginning of therapy. It improves working capacity and social adaptation of patients. The drug does not provoke addiction.

Posology and Administration

Modes of administration in adults: orally, regardless of meal, 4 mg 2 times a day (8 mg/daily); in case of an insufficient clinical effect after 3 weeks it is possible to increase a dose up to 10 mg/daily.
In elderly patients (over 65 years of age) and in patients of kidney failure or moderately evidenced liver failure – 2 mg 2 times a day (4 mg/daily) increasing a dose after 3 weeks (if needed) up to 6 mg/daily.
Safety and efficiency of the use in children are not defined.

Counterindications

Hypersensitivity to Reboxetine, pregnancy, breastfeeding, childhood under 18 years of age (safety and efficiency of the use in children are not defined).

Should Be Taken with Precautions, if?

Do not start Reboxetine therapy without advice of your attending doctor in pregnancy (including that of supposed) and in lactation period. Caution should be taken in administration to patients with elevated probability of convulsive attacks (if an attack progresses during the therapy it is necessary to stop the administration), in seasonal psychic disorders, in evident kidney failure, urination retention, glaucoma, in unnormalized arterial tension.

Interface with Other Medications

On the matters of a parallel administration of other drugs during Reboxitine therapy seek your attending doctor.

Overdosing

Symptoms: decrease of arterial tension, weakness, faintness, blackout during rising from a sitting or horizontal position, high intracranial pressure, high tension, anxiety.

Side Effects

Insomnia, dizziness, dry mouth, urinary difficulty, constipation, indigestion, high perspiration, tachycardia, weakness, impotency (with doses more than 8 mg/daily).

Pregnancy and Lactation

The use of the drug is possible is a supposed therapy efficiency exceeds a potential risk for the fetus. It is not recommended in the period of breastfeeding (there are no data on safety of the use in breastfeeding women).

Driving

Reboxitine has a series of the side effects not compatible with the activities requiring alertness (including driving of vehicles). Likelihood of your driving vehicles depends on your reaction on the drug.